Results 1 to 10 of about 198,987 (238)

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy [PDF]

open access: yesInfect Drug Resist, 2022
Masafumi Seki,1,2 Kosuke Hashimoto,2 Nami Kondo,2 Yoshitaka Ohya,2 Futoshi Kotajima,2 Kotaro Mitsutake1,2 1Division of Infectious Diseases and Infection Control, International Medical Center, Saitama Medical University, Hidaka City, Saitama, Japan ...
Kondo N   +5 more
core   +2 more sources

Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]

open access: yesFront Immunol
Pemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Lang Yu   +4 more
core   +2 more sources

Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases [PDF]

open access: yesPathogens, 2023
There are about 200 different types of interstitial lung disease (ILD), and a crucial initial step in the assessment of a patient with suspected ILD is achieving an appropriate diagnosis.
Ruxana T. Sadikot, Said Chaaban
core   +2 more sources

Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study [PDF]

open access: yesArthritis Res Ther
Background To investigate cancer incidence and the potential influence of immunosuppressive agents in Korean systemic lupus erythematosus (SLE) patients.
Yena Jeon   +6 more
core   +2 more sources

New immunosuppressive agents in transplantation

open access: yes, 2022
International audienceImmunosuppressive agents have enabled the development of allogenic transplantation during the last 40 years, allowing considerable improvement in graft survival.
Kervella, Delphine, Blancho, Gilles
core   +1 more source

Statins as immunosuppressive agents [PDF]

open access: yesLiver Transplantation, 2001
Abstract Unavailable. Please See Print Journal.
openaire   +2 more sources

Immunosuppressive agents for treating IgA nephropathy [PDF]

open access: yes, 2020
Background: IgA nephropathy is the most common glomerulonephritis world-wide. IgA nephropathy causes end-stage kidney disease (ESKD) in 15% to 20% of affected patients within 10 years and in 30% to 40% of patients within 20 years from the onset of ...
Natale P.   +19 more
core   +1 more source

New immunosuppressive agents in pediatric transplantation

open access: yes, 2014
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival.
Shapiro, Ron   +3 more
core   +1 more source

Impact of immunosuppressive agents on clinical manifestations and outcome of ‘Staphylococcus aureus’ bloodstream infection: a propensity score–matched analysis in 2 large, prospectively evaluated cohorts

open access: yes, 2021
Background Staphylococcus aureus bloodstream infection (SAB) is a common, life-threatening infection. The impact of immunosuppressive agents on the outcome of patients with SAB is incompletely understood.
Glaubitz, Lina   +26 more
core   +3 more sources

Nephrotoxicity of immunosuppressive agents in renal transplantation

open access: yes, 2002
The outcome of solid organ transplantation has improved significantly in the past few decades with the advent of cyclosporine and other newer immunosuppressive agents including tacrolimus, mycophenolate mofetil, interleukin-2 receptor blockers, and ...
Chan, TM   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy